![Oxford Biomedica](https://storage.googleapis.com/dealroom-images-production/dd/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDIyLzA0LzE5LzUwMmU4OTA1Zjk0ZTBiOWUxYWZmMmFiNGVhZjc2YzY5.png)
Oxford Biomedica
Verified Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$489m (Public information from Jul 2024)
Share price
£3.67264 OXB.L
Company register number 03252665
Oxford England (HQ)
GBP | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 37 % | 63 % | (2 %) | (35 %) | 44 % | 25 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (10 %) | 6 % | 23 % | (17 %) | (60 %) | (8 %) | 9 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (25 %) | (7 %) | 13 % | (28 %) | (99 %) | (27 %) | (13 %) |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 35 % | 34 % | 28 % | 44 % | - | - | - |
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | $0.0 | round |
N/A | $0.0 | round | |
N/A | $0.0 | round | |
N/A | $0.0 | round | |
investor | $0.0 | round | |
investor | $0.0 | round | |
£50.0m | Post IPO Equity | ||
Total Funding | 000k |
Related Content
Recent News about Oxford Biomedica
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.